drugset / Trial / NCT04328272
Effectiveness of Hydroxychloroquine in Covid-19 Patients
RandomizedParallel-groupSingle-blindTreatment
Summary
To find the effectiveness of hydroxychloroquine alone and adjuvant with azithromycin in mild to severe Covide-19 pneumonia patients admitted to Coronavirus cell/ward of Ayub Teaching hospital, Abbottabad Pakistan. A single centered, single-blind randomized control trial study.
Timeline
- Start
- 2020-03-28
- Primary completion
- 2020-05-28
- Completion
- 2020-06-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azithromycin | Small molecule | 250 mg | Oral |
| Subject | Hydroxychloroquine | Small molecule | 400 mg | Oral |